Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Herbert

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Pediatric Neurology|November 25, 2025
Behavioral and Emotional Challenges in Children With Spinal Muscular AtrophyLakshmi Balaji, Didu S Kariyawasam, Karen Herbert, et al.
Journal of Economic Entomology|January 13, 2009
Developing and testing a diagnostic probe for grape phylloxera applicable to soil samplesKaren Herbert, Kevin Powell, Alan Mckay, et al.
The Lancet. Child & Adolescent Health|January 20, 2023
Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort studyDidu S Kariyawasam, Arlene M D'Silva, Hugo Sampaio, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 27, 2020
Motor unit changes in children with symptomatic spinal muscular atrophy treated with nusinersenDidu Kariyawasam, Arlene D'Silva, James Howells, et al.
The Lancet Regional Health. Western Pacific|May 8, 2026
Adaptive functioning in school-aged children with spinal muscular atrophy in the treatment era: a non-randomised cohort studyEmily E Farah, Sarah-Grace Paguinto, Melissa R Mandarakas, et al.
Neurology|June 27, 2025
Gestational Age at Birth and Clinical Manifestations of Spinal Muscular AtrophyMichelle Anne Farrar, Melissa Mandarakas, Nancy Briggs, et al.
The Journal of Physiology|November 16, 2021
Axonal excitability changes in children with spinal muscular atrophy treated with nusinersenDidu S T Kariyawasam, Arlene M D'Silva, Karen Herbert, et al.
Brain Communications|August 13, 2025
Neurodevelopmental screening in children with early-onset spinal muscular atrophy in the treatment era: a strengths-based cohort studyLakshmi Balaji, Didu Kariyawasam, Karen Herbert, et al.
Annals of Neurology|March 18, 2026
The Dynamics of Neurofilament Light Chain in Spinal Muscular AtrophyArlene D'Silva, Karen Herbert, Lakshmi Balaji, et al.
Annals of Clinical and Translational Neurology|February 16, 2022
Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacyArlene M D'Silva, Sandra Holland, Didu Kariyawasam, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Pediatric Neurology|November 25, 2025
Behavioral and Emotional Challenges in Children With Spinal Muscular AtrophyLakshmi Balaji, Didu S Kariyawasam, Karen Herbert, et al.
Journal of Economic Entomology|January 13, 2009
Developing and testing a diagnostic probe for grape phylloxera applicable to soil samplesKaren Herbert, Kevin Powell, Alan Mckay, et al.
The Lancet. Child & Adolescent Health|January 20, 2023
Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort studyDidu S Kariyawasam, Arlene M D'Silva, Hugo Sampaio, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 27, 2020
Motor unit changes in children with symptomatic spinal muscular atrophy treated with nusinersenDidu Kariyawasam, Arlene D'Silva, James Howells, et al.
The Lancet Regional Health. Western Pacific|May 8, 2026
Adaptive functioning in school-aged children with spinal muscular atrophy in the treatment era: a non-randomised cohort studyEmily E Farah, Sarah-Grace Paguinto, Melissa R Mandarakas, et al.
Neurology|June 27, 2025
Gestational Age at Birth and Clinical Manifestations of Spinal Muscular AtrophyMichelle Anne Farrar, Melissa Mandarakas, Nancy Briggs, et al.
The Journal of Physiology|November 16, 2021
Axonal excitability changes in children with spinal muscular atrophy treated with nusinersenDidu S T Kariyawasam, Arlene M D'Silva, Karen Herbert, et al.
Brain Communications|August 13, 2025
Neurodevelopmental screening in children with early-onset spinal muscular atrophy in the treatment era: a strengths-based cohort studyLakshmi Balaji, Didu Kariyawasam, Karen Herbert, et al.
Annals of Neurology|March 18, 2026
The Dynamics of Neurofilament Light Chain in Spinal Muscular AtrophyArlene D'Silva, Karen Herbert, Lakshmi Balaji, et al.
Annals of Clinical and Translational Neurology|February 16, 2022
Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacyArlene M D'Silva, Sandra Holland, Didu Kariyawasam, et al.
Pageof 2